Condition (sample size) | Outcome Measure | Change in Outcome Measure | Reference | Comments |
---|---|---|---|---|
Diabetes (42) | HbA1c | 13.2% decrease (intervention) v. 8.9% decrease control) | [14] | Duration = 3 months |
Diabetes (142) | Prevalence of hypoglycemia HbA1c | Decrease from 3% to 2% Decrease from 9.7 to 8.6 | [20] | Change in HbA1c statistically significant Duration = 1 year |
Diabetes (10) | HbA1c | 1.2% decrease (intervention) v. 0.8% increase (control) | [22] | Duration = 6 months |
Diabetes (185) | HbA1c | Decrease in 0.5 units | [34] | Duration = 3 months |
Diabetes (100) | HbA1c | No change | [41] | Duration = 1 year |
Tuberculosis (6) | Adherence to medication | Similar adherence outcomes between intervention and control | [16] | Duration = 2 years |
Hypertension (267) | Adherence | 17.7% adherence improvement (intervention) v. 11.7% control | [18] | Duration = 6 months |
Hypertension (104) | Adherence | No effect on compliance | [35] | Duration = 4 months |
Asthma (16) | Lung capacity Compliance | No effect on absolute lung peak expiratory flow (PEF) and medicine compliance | [39] | Duration = 4 months |